400 likes | 883 Views
Drug Induced Arrhythmia. Dr. SH TSUI 15 June 2005. ECG Disturbances in Poisoned Patients. Fast rate Slow rate Abnormal rhythm/pattern Focus: Underlying mechanism and patho-physiology. Cardiovascular Physiology . Electrolyte movement and action potential.
E N D
Drug Induced Arrhythmia Dr. SH TSUI 15 June 2005
ECG Disturbances in Poisoned Patients • Fast rate • Slow rate • Abnormal rhythm/pattern Focus: Underlying mechanism and patho-physiology
Cardiovascular Physiology • Electrolyte movement and action potential
Cardiovascular Toxicity Mediated by affecting: • Calcium channel • Sodium channel • Potassium channel • Na-K-ATPase Pump • Electrolyte disturbances • Autonomic nervous system
Drug Induced Tachycardia 1 Enhanced SYM tone • Response to increases substrate requirement • Tissue hypoxia • Hypoglycaemia • Increased centrally mediated psychomotor activity CO Salicylates All stimulants
Drug Induced Tachycardia 1 Enhanced SYM tone 2. SYM stimulation • Direct central activation • Direct peripheral Withdrawal Cocaine Amphetamine Theophylline
Drug Induced Tachycardia 2 Reflexive Response • Response to contractility • Response to vasodilatation • Response to hypovolaemia TCA Salicylates
Drug Induced Tachycardia 3 Parasympathetic antagonism • Antagonism of Ach receptors on the myocardium • Release of Ach from the nerve terminal
Drug Induced Tachycardia 4 Enhanced myocardial sensitization • sensitivity to catecholamines • Predispose to tachycardia and arrhthymia Halogenated Hydrocarbon
F: A: S: T: Free base or other forms of cocaine Anticholinergics, Antihistamines, Amphetamines, Antipsychotics Sympathomimetics, Solvent abuse Theophylline Mnemonics
Drug Induced Bradycardia 1 Altered autonomic tone • Enhanced cholinergic tone • Increased central PARA tone • Cholinesterase inhibition Central Myocardial muscarinic Ach receptors Organophosphates
Drug Induced Bradycardia 1 Altered autonomic tone • Altered SYM tone 1. 2. Clonidine/Imidazolines 3. Depletion of circulating catecholamines Sedative-hypnotic Central α2 agonism SYM output
Drug Induced Bradycardia 1 Reflex response • Baroreceptor reflex response to HT PPA
Drug Induced Bradycardia 2 Toxicity on conduction and pacemakers • Mediated by affecting: • Na/K ATPase pump • Sodium channel • ß1 Adrenergic receptor • Potassium channel • Calcium channel
Calcium Channel Blockers • Inhibits SA and AV nodal conduction resulting in bradycardia and heart block
CCB Toxicity: Treatments • Atropine • Calcium • Catecholamines • Insulin • Glucagon • Phosphodiesterase inhibitor
ß Blockers Toxicity • Decrease SA node function • Impaired AV conduction • Prolonged QRS (Membrane stabilizing activities) • Prolonged QT intervals (K channel Blockade)
ß Blockers Toxicity: Treatment • Atropine • Glucagon • Calcium • Insulin • Catecholamines • Phosphodiesterase inhibitor
P: A: C: E: D: Propranolol(ß-blockers), Poppies Anticholinesterase, Aconitine Clonidine, CCB, Ciguatera Ethanol or other alcohols Digoxin Mnemonics
Arrhythmia Underlying mechanisms • Increased automaticity • Re-entry • Triggered automaticity • Delayed after depolarization • Early after depolarization
Automaticity: Digoxin • Excessive elevation of the intracellular calcium elevates the resting potential • Producing increased automaticity
TCA Terminal right axis deviation • RBB is preferentially affected • Appearance of right ventricular force at the late phase of QRS
Predictive Values QRS duration • Seizures: 0% if <100ms, 30% if >100ms • Ventricular dysrhythmias: 0% if <160ms, 50% if >160ms Boehnert M, N Eng J Med 1985 313;474-479
Predictive Values • Amplitude of terminal R wave in aVR: RaVR3mm predicts seizures and dysrhythmia Liebelt EL Ann Emerg Med 1995;26:195-201 • Terminal R-axis deviation, prolonged QTc, sinus tachycardia: specific and sensitive for TCA OD Wolfe TR Ann Emerg Med 1989;18:348-351
TCA: tachyarrhythmia VT Mechanisms • Non-uniform conduction slowing Re-entry • Precipitated by hypoxia, tissue ischaemia and metabolic acidosis Sinus tachycardia plus aberrancy is more common
Delayed After-depolarization • Normal depolarization is followed by an oscillation during phase 4 • Occurs with intracellular Ca • E.g. Cardiac glycoside toxicity
Digoxin Toxicity: Risks of treatment • Pacing: DAD amplitude • Overdrive supression: Useless in dysrhythmias due to automaticity • DC version: Risk of inducing VF/VT • Treatment choices: Atropine, Lignocaine, Phenytoin, Amiodarone *Digoxin antibody
Early After-depolarization • Occurs during the downslope of phase 3 of the action potential • Occurs when cardiac action potential is markedly prolonged ( QTc)
Aconitine Toxicity • Na influx through Na channel • Delay the final phase of repolarization and promote premature excitation • Expect Na channel blockers to be effective • Amiodarone, flecainide, procainamide have been reported to be successful in terminating ventricular dysrhthymias
Treatment of Drug-induced ventricular dysrhythmias • NaHCO3 if widened QRS • Lignocaine for prolonged QT • Mg, DC version, Overdrive pacing for Torsades de pointes, correct e-
Toxin Induced SVT • Usually mediated by sympathomimetic activity of drugs • Cardioversion • Adenosine: may not be effective for methylxanthines toxicity • CCB and ß-blockers: risks • Toxin removal
Conclusion • Understanding the underlying patho-physiology of toxin induced arrhythmias improves our diagnosis and treatment of such problems